Cipla expects surge in demand for respiratory drugs, inhalers in winter

The firm enjoys a massive 68.7 per cent market share in the respiratory inhalation segment in India and has started working on aligning supplies so that there is no shortage of these critical medicine
Read More

Leave a Reply

Your email address will not be published.